AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

Search

Oxford Biomedica PLC

Uždarymo kaina

334 -0.6

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

332

Max

342.5

Pagrindiniai rodikliai

By Trading Economics

Pajamos

22M

-11M

Pardavimai

27M

78M

Pelno marža

-13.726

Darbuotojai

850

EBITDA

25M

5M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+87.57% upside

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

40M

348M

Ankstesnė atidarymo kaina

334.6

Ankstesnė uždarymo kaina

334

Oxford Biomedica PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-05 20:45; UTC

Uždarbis

Broadcom 2Q Sales Climb on Booming AI Demand

2025-06-05 23:45; UTC

Rinkos pokalbiai

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

2025-06-05 23:44; UTC

Rinkos pokalbiai

Gold Edges Higher on Weak U.S. Data -- Market Talk

2025-06-05 23:30; UTC

Rinkos pokalbiai

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

2025-06-05 21:32; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 20:45; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:24; UTC

Uždarbis

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Rev $15B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Net $4.97B >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q Adj EPS $1.58 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom 2Q EPS $1.03 >AVGO

2025-06-05 20:15; UTC

Uždarbis

Broadcom Sees 3Q Rev $15.8B >AVGO

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

2025-06-05 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

2025-06-05 19:22; UTC

Rinkos pokalbiai

Oil Futures Resume Upward Moves -- Market Talk

2025-06-05 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

2025-06-05 18:32; UTC

Rinkos pokalbiai

Gold Slips After Trump-Xi Call -- Market Talk

2025-06-05 18:26; UTC

Uždarbis

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

2025-06-05 18:06; UTC

Rinkos pokalbiai

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

2025-06-05 16:30; UTC

Įsigijimai, susijungimai, perėmimai

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

2025-06-05 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-06-05 16:18; UTC

Rinkos pokalbiai

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

2025-06-05 16:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-06-05 16:12; UTC

Rinkos pokalbiai

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

2025-06-05 16:03; UTC

Rinkos pokalbiai

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

2025-06-05 15:49; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Oxford Biomedica PLC Prognozė

Kainos tikslas

By TipRanks

87.57% į viršų

12 mėnesių prognozė

Vidutinis 649.002 GBX  87.57%

Aukščiausias 798.369 GBX

Žemiausias 498.981 GBX

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Oxford Biomedica PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.